ASRTAssertio Holdings, Inc.

ASRT Stock Price, Valuation & Chart | Assertio Holdings, Inc.

$23.500+0.00 (+0.00%)

At close · 15 June 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic ASRT intrinsic value ASRT calculated fair value vs price

Overview Financials Dividends Ratios

ASRT Historical price chart

ASRT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization151.86M

PE Ratio-7.1

EPS-3.31

Trading Volume270.19K

Today's High/Low23.5/23.48

Dividend Yield0.00

52 Week High/Low23.5/8.61

Shares Outstanding6.46M

ASRT Financial Statement

ASRT Analyst ratings

ASRT Analysis & performance metrics

ASRT Company profile

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products…

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute…

ASRT Management team

Name

Position

Paul Schwichtenberg

Executive Vice President & Chief Transformation Officer

Bill Iskos

Senior Vice President of Operations

Molly Dir

Senior Vice President of HR & Administration

Brendan P. O'GradyCEO

Chief Executive Officer & Director

Sam Schlessinger

Executive Vice President & General Counsel

Mary Pietryga

Executive Vice President & Chief Commercial Officer

Ajay PatelCFO

Executive Vice President & Chief Financial Officer

Howard J. Franklin M.B.A., M.D.

Senior Vice President of Medical

Name

Position

Paul Schwichtenberg

Executive Vice President & Chief Transformation Officer

Bill Iskos

Senior Vice President of Operations

Molly Dir

Senior Vice President of HR & Administration

Brendan P. O'GradyCEO

Chief Executive Officer & Director

Sam Schlessinger

Executive Vice President & General Counsel

Mary Pietryga

Executive Vice President & Chief Commercial Officer

Ajay PatelCFO

Executive Vice President & Chief Financial Officer

Howard J. Franklin M.B.A., M.D.

Senior Vice President of Medical

Management Team

Paul Schwichtenberg

Executive Vice President & Chief Transformation Officer

Bill Iskos

Senior Vice President of Operations

Molly Dir

Senior Vice President of HR & Administration

Brendan P. O'GradyCEO

Chief Executive Officer & Director

Sam Schlessinger

Executive Vice President & General Counsel

Mary Pietryga

Executive Vice President & Chief Commercial Officer

Ajay PatelCFO

Executive Vice President & Chief Financial Officer

Howard J. Franklin M.B.A., M.D.

Senior Vice President of Medical

Management

Paul Schwichtenberg

Executive Vice President & Chief Transformation Officer

Bill Iskos

Senior Vice President of Operations

Molly Dir

Senior Vice President of HR & Administration

Brendan P. O'GradyCEO

Chief Executive Officer & Director

Sam Schlessinger

Executive Vice President & General Counsel

Mary Pietryga

Executive Vice President & Chief Commercial Officer

Ajay PatelCFO

Executive Vice President & Chief Financial Officer

Howard J. Franklin M.B.A., M.D.

Senior Vice President of Medical

Total 8 executives

ASRT Frequently asked questions

What is Assertio Holdings, Inc. (ASRT) Stock Price?

Current stock price of Assertio Holdings, Inc. (ASRT) stock is $23.500. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Assertio Holdings, Inc. (ASRT) stock is 270.19K.

Last updated at 15 June 2026, 08:00 pm.

Why is the Assertio Holdings, Inc. (ASRT) stock price going up or down today?

The stock price of Assertio Holdings, Inc. (ASRT) can change with earnings, company news, and overall market sentiment. Assertio Holdings, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Assertio Holdings, Inc. stock expensive at its current price?

Whether Assertio Holdings, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ASRT on this page is -7.10. EPS on this page is -3.31. Compare those figures with peers and growth expectations before deciding if the current Assertio Holdings, Inc. price is justified.

How has the stock price of Assertio Holdings, Inc. (ASRT) performed historically?

Historical performance for Assertio Holdings, Inc. (ASRT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ASRT reacted to past earnings and market events.

Should I buy Assertio Holdings, Inc. (ASRT) stock, at this price?

Buying Assertio Holdings, Inc. (ASRT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.